The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Open accessAbstract
Background: From December 2019 to February 2020, 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China. Related clinical features are needed. Methods: We reviewed 69 patients who were hospitalized in Union hospital in Wuhan between 16 January and 29 January 2020. All patients were confirmed to be infected with SARS-CoV-2, and the final date of follow-up was 4 February 2020. Results: The median age of 69 enrolled patients was 42.0 years (interquartile range 35.0–62.0), and 32 patients (46%) were men. The most common symptoms were fever (60 [87%]), cough (38 [55%]), and fatigue (29 [42%]). Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and 5 patients had died, with a mortality rate of 7.5%. According to the lowest SpO2 during admission, cases were divided into the SpO2 ≥ 90% group (n = 55) and the SpO2 < 90% group (n = 14). All 5 deaths occurred in the SpO2 < 90% group. Compared with SpO2 ≥ 90% group, patients of the SpO2 < 90% group were older and showed more comorbidities and higher plasma levels of interleukin (IL) 6, IL10, lactate dehydrogenase, and C reactive protein. Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate. Conclusions: COVID-19 appears to show frequent fever, dry cough, and increase of inflammatory cytokines, and induced a mortality rate of 7.5%. Older patients or those with underlying comorbidities are at higher risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients infected with SARS-CoV-2 present elevated levels of IL-6, IL-10, IL-1β, INF-γ, CCL2, TNF-α, CXCL10, CCL7, IL-1 receptor antagonist and IL-2 receptor, supposedly associated with disease severity [9, 98–105].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [105]
In the citing paper
“The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection.”
From Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study (2020) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Self-citationLu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationChan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638
Research works printed but not linked: 2
- National Health Commission of China, Guideline of management of COVID-19 (version 3)
- National Health Commission of China, Guideline of management of COVID-19 (version 7)
Cited by
Sorted by citations
Items 301–400 of 1,001
Preemptive interleukin-6 blockade in patients with COVID-19
Guillén, L., Padilla, S., Fernández‐González, M., Agulló, V., García, J. A., Telenti, G., García‐Abellán, J., Botella, Á., Gutiérrez, F., & Masiá, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74001-3 · Cited by 46
Yan, F., Li, E., Wang, T., Li, Y., Liu, J., Wang, W., Qin, T., Su, R., Pei, H., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821664 · Cited by 44
Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19
Miller, L. E., Bhattacharyya, R., & Miller, A. L. (2020) · Medicine · doi:10.1097/md.0000000000022439 · Cited by 46
Myosteatosis predicting risk of transition to severe COVID-19 infection
Yi, X., Liu, H., Zhu, L., Wang, D., Xie, F., Shi, L., Ji, M., Jiang, X., Zeng, Q., Hu, P.-F., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.031 · Cited by 46
Cheng, L. S., Chau, S. K., Tso, E. Y. K., Tsang, S., Li, I. Y.-F., Wong, B. K. C., & Fung, K. S.-C. (2020) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120978095 · Cited by 45
Neutrophils at the crossroads of acute viral infections and severity
Rawat, S., Vrati, S., & Banerjee, A. K. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100996 · Cited by 49
Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
Davis, B., Rothrock, A. N., Swetland, S. B., Andris, H., Davis, P. J., & Rothrock, S. G. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12128 · Cited by 44
Shen, Y. H., Anwar, T. B., & Mulchandani, A. (2021) · Sensors and Actuators Reports · doi:10.1016/j.snr.2021.100025 · Cited by 44
Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
Bzeizi, K. I., Abdulla, M., Mohammed, N., AlQamish, J., Jamshidi, N., & Broering, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-89513-9 · Cited by 45
Gülşen, A., König, I. R., Jappe, U., & Drömann, D. (2021) · Respirology · doi:10.1111/resp.14049 · Cited by 43
Eosinophil count in severe coronavirus disease 2019
Lippi, G., & Henry, B. M. (2020) · QJM · doi:10.1093/qjmed/hcaa137 · Cited by 43
Clinical Presentation of Patients Infected with Coronavirus Disease 19: A Systematic Review
Sheleme, T., Bekele, F., & Ayela, T. (2020) · Infectious Diseases Research and Treatment · doi:10.1177/1178633720952076 · Cited by 43
Bashash, D., Hosseini‐Baharanchi, F. S., Rezaei–Tavirani, M., Safa, M., Dilmaghani, N. A., Faranoush, M., & Abolghasemi, H. (2020) · Archives of Academic Emergency Medicine · Cited by 42
Sharun, K., Tiwari, R., Yatoo, M. I., Natesan, S., Megawati, D., Singh, K. P., Michalak, I., & Dhama, K. (2022) · Narra J · doi:10.52225/narra.v2i3.92 · Cited by 42
A cooperativity between virus and bacteria during respiratory infections
Lalbiaktluangi, C., Yadav, M., Singh, P. K., Singh, A., Iyer, M., Vellingiri, B., Zomuansangi, R., Zothanpuia, Z., & Ram, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1279159 · Cited by 43
Xie, J., Wang, Q., Xu, Y., Zhang, T., Chen, L., Zuo, X., Liu, J., Huang, L., Zhan, P., Lv, T., et al. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-1863 · Cited by 43
Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic
Kazemian, N., Kao, D. H., & Pakpour, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063004 · Cited by 41
Lisi, L., Lacal, P. M., Barbaccia, M. L., & Graziani, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114169 · Cited by 42
Ueyama, H. A., Kuno, T., Takagi, H., Krishnamoorthy, P. M., Vengrenyuk, Y., Sharma, S. K., Kini, A. S., & Lerakis, S. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000148 · Cited by 41
Giri, M., Puri, A., Wang, T., & Guo, S. (2021) · Science Progress · doi:10.1177/00368504211000906 · Cited by 41
Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
Muralidar, S., Gopal, G., & Ambi, S. V. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27019 · Cited by 42
Ding, T., Zhang, J., Wang, T., Cui, P., Chen, Z., Jiang, J., Zhou, S., Dai, J., Wang, B., Yuan, S., et al. (2020) · medRxiv · doi:10.1101/2020.03.26.20043943 · Cited by 41
A comprehensive review on potential therapeutics interventions for COVID-19
Chugh, H., Awasthi, A., Agarwal, Y., Gaur, R. K., Dhawan, G., & Chandra, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173741 · Cited by 44
Predictive Value of Prognostic Nutritional Index on COVID-19 Severity
Wang, Z., Lin, Y., Wei, X., Li, F., Liao, X., Yuan, H., Huang, D., Qin, T., Geng, H., & Wang, S.-H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.582736 · Cited by 40
Self-citationGusev, E., Sarapultsev, A., Hu, D., & Черешнев, В. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147582 · Cited by 42
Patient follow‐up after discharge after COVID‐19 pneumonia: Considerations for infectious control
Zheng, Z., Yao, Z., Wu, K., & Zheng, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25994 · Cited by 38
Hoiland, R. L., Stukas, S. K., Cooper, J. G., Thiara, S., Chen, L. Y. C., Biggs, C. M., Hay, K. A., Lee, A. Y. Y., Shojania, K., Abdulla, A., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16961 · Cited by 39
Boregowda, U. N., Aloysius, M. M., Perisetti, A., Gajendran, M., Bansal, P., & Goyal, H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00431 · Cited by 40
Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis
Aziz, M. (2020) · Annals of Gastroenterology · doi:10.20524/aog.2020.0527 · Cited by 39
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
Cacciapuoti, S., Rosa, A. D., Gelzo, M., Megna, M., Raia, M., Pinchera, B., Pontarelli, A., Scotto, R., Scala, E., Scarano, F., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118355 · Cited by 39
The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis
Kazemi, E., Nejat, R. S., Ashkan, F., & Sheibani, H. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00420-3 · Cited by 39
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Yang, M., Yang, Y., He, Q., Zhu, P., Liu, M., Xu, J., & Zhao, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676232 · Cited by 41
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M. W., Untersmayr, E., Hoffmann‐Sommergruber, K., Vultaggio, A., Agache, I. O., et al. (2020) · Allergologie select · doi:10.5414/alx02166e · Cited by 38
The association between COVID‐19 and asthma: A systematic review and meta‐analysis
Wang, Y., Ao, G., Qi, X., & Xie, B. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13733 · Cited by 38
Israfil, S. M. H., Sarker, M. M. R., Rashid, P. T., Talukder, A. A., Kawsar, K. A., Khan, F. I., Akhter, S., Poh, C. L., Mohamed, I. N., & Ming, L. C. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.567395 · Cited by 38
Thyroid cancer in the age of COVID-19
Tsang, V., Gild, M. L., Glover, A. R., Clifton-Bligh, R. J., & Robinson, B. G. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0279 · Cited by 39
Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis
Farré, N., Mojón, D., Llagostera, M., Tornero, L. C. B., Calvo-Fernández, A., Vallès, E., Negrete, A., García-Guimarães, M., Bartolomé, Y., Fernández, C., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092712 · Cited by 38
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial CoinfectionPreprint
Wei, W., Ortwine, J. K., Mang, N. S., Joseph, C., Hall, B. C., & Prokesch, B. C. (2020) · medRxiv · doi:10.1101/2020.06.16.20133181 · Cited by 42
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Canedo-Marroquín, G., Saavedra, F., Andrade, C. A., Berríos-Rojas, R. V., Rodríguez‐Guilarte, L., Opazo, M. C., Riedel, C. A., & Kalergis, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569760 · Cited by 40
Avery, T. M., Boone, R. L., Lu, J., Spicer, S. K., Guevara, M. A., Moore, R. E., Chambers, S. A., Manning, S. D., Dent, L., Marshall, D. R., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00087 · Cited by 37
Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity
Rahnavard, A., Mann, B. T., Giri, A., Chatterjee, R., & Crandall, K. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-16396-9 · Cited by 36
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
Budhathoki, P., Shrestha, D. B., Rawal, E., & Khadka, S. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00515-6 · Cited by 38
Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis
Pinto, L. C. F., & Bertoluci, M. C. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000256 · Cited by 36
Yang, B. D., Fulcher, J. A., Ahn, J., Berro, M., Goodman‐Meza, D., Dhody, K., Sacha, J. B., Naeim, A., & Yang, O. O. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1583 · Cited by 37
Self-citationRecent progress of antiviral therapy for coronavirus disease 2019
Zhao, M., Zhang, J., Li, H., Luo, Z., Ye, J., Xu, Y. Q., Wang, Z., Ye, D., Liu, J., Li, D., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173646 · Cited by 37
Self-citationHosseinzadeh, R., Goharrizi, M. A. S. B., Bahardoust, M., Alvanegh, A. G., Ataee, M. R., Bagheri, M., Navidiyan, E. S., Zijoud, S. R. H., & Heiat, M. (2021) · Clinical Hypertension · doi:10.1186/s40885-021-00161-7 · Cited by 37
Fu, J., Wei, C., He, J., Zhang, L., Zhou, J., Balaji, K. S., Shen, S., Peng, J., Sharma, A., & Fu, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.54055 · Cited by 35
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
Maio, M., Hamid, O., Larkin, J., Covre, A., Altomonte, M., Calabrò, L., Vardhana, S. A., Robert, C., Ibrahim, R. A., Anichini, A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1657 · Cited by 35
Jafrin, S., Aziz, M. A., & Islam, M. S. (2022) · Biomarker Insights · doi:10.1177/11772719221106600 · Cited by 37
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
An, P., Zhu, Y. Z., & Yang, L.-P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104946 · Cited by 35
Wright, W. F., & Mackowiak, P. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa603 · Cited by 35
Ghimire, S., Sharma, S., Patel, A., Budhathoki, R., Chakinala, R. C., Khan, H. M. A., Lincoln, M. J., & Georgeston, M. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00662-w · Cited by 35
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside
Laracy, J. C., Kamboj, M., & Vardhana, S. A. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000841 · Cited by 34
Jin, M., Lu, Z., Zhang, X., Wang, Y., Wang, J., Cai, Y., Tian, K., Xiong, Z., Zhong, Q., Ran, X., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06585-8 · Cited by 34
Self-citationSanctis, V. D. (2020) · PubMed Central · doi:10.23750/abm.v91i4.10540 · Cited by 34
Exosomes contribution in COVID-19 patients’ treatment
Mazini, L., Rochette, L., & Malka, G. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02884-5 · Cited by 34
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era
Khanna, S., & Pardi, D. S. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000689 · Cited by 35
Wu, X., Liu, L., Jiao, J., Yang, L., Zhu, B., & Li, X. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1802061 · Cited by 34
Hill, J. A., Menon, M. P., Dhanireddy, S., Wurfel, M. M., Green, M., Jain, R., Chan, J. D., Huang, J., Bethune, D., Turtle, C. J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26674 · Cited by 33
Bsteh, G., Assar, H., Hegen, H., Heschl, B., Leutmezer, F., Pauli, F. D., Gradl, C., Traxler, G., Zulehner, G., Rommer, P. S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255316 · Cited by 35
The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review
Korres, G. S., Kitsos, D. K., Kaski, D. N., Tsogka, A., Giannopoulos, S., Giannopapas, V., Sideris, G., Tyrellis, G., & Voumvourakis, K. I. (2022) · Brain Sciences · doi:10.3390/brainsci12070948 · Cited by 37
COVID-19: The Immune Responses and Clinical Therapy Candidates
Zhand, S., Jazi, M. S., Mohammadi, S., Rasekhi, R. T., Rostamian, G., Kalani, M. R., Rostamian, A., George, J., & Douglas, M. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155559 · Cited by 35
Liaqat, A., Ali-Khan, R. S., Asad, M., Rafique, Z., Hasan, S. S., Page, A. T., & Qin, X. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84467-4 · Cited by 33
Born, J., Manica, M., Cadow, J., Markert, G., Mill, N. A., Filipavicius, M., Janakarajan, N., Cardinale, A., Laino, T., & Martínez, M. R. (2021) · Machine Learning Science and Technology · doi:10.1088/2632-2153/abe808 · Cited by 35
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
Wadaa-Allah, A., Emhemed, M. S., Sadeq, M. A., Dahman, N. B. H., Ullah, I., Farrag, N. S., & Negida, A. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1875500 · Cited by 32
Wu, Y., Li, H., Zhang, Z., Liang, W., Zhang, T., Tong, Z., Guo, X., & Qi, X. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-2557 · Cited by 33
Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
Farhang‐Sardroodi, S., Korosec, C. S., Gholami, S., Craig, M., Moyles, I. R., Ghaemi, M. S., Ooi, H. K., & Heffernan, J. M. (2021) · Vaccines · doi:10.3390/vaccines9080861 · Cited by 33
Principais diagnósticos de enfermagem em pacientes com manifestações clínicas da COVID-19
Andrade, T. R. S. F., Santos, I. H. A., Rezende, G. E. S., Torres, E. C., Marques, C. R. D. G., Dias, E. S., Hora, A. B., Cavalcante, A. B., de Jesus, C. V. F., & Ferrari, Y. A. C. (2020) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e4883.2020 · Cited by 32
COVID‐19: A review of therapeutics under investigation
Crosby, J., Heimann, M. A., Burleson, S. L., Anzalone, B. C., Swanson, J. F., Wallace, D. W., & Greene, C. J. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12081 · Cited by 32
The value of serum amyloid A for predicting the severity and recovery of COVID‑19
Fu, J. F., Huang, P., Zhang, S., Yao, Q., Han, R., Liu, H., Yang, Y., & Zhang, D. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9114 · Cited by 32
PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19
Palma, G., Pasqua, T., Silvestri, G., Rocca, C., Gualtieri, P., Barbieri, A., Bartolo, A. D., LORENZO, A. D., Angelone, T., Avolio, E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02094 · Cited by 33
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
Seth, G., Sethi, S., Bhattarai, S., Saini, G., Singh, C. B., & Aneja, R. (2020) · Cancers · doi:10.3390/cancers12113266 · Cited by 32
Miao, Q., Ma, Y., Ling, Y., Jin, W., Su, Y. N., Wang, Q., Pan, J., Zhang, Y., Chen, H.-Y., Yuan, J., et al. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.015 · Cited by 32
Shuster, A., Pechalrieu, D., Jackson, C. B., Abegg, D., Choe, H., & Adibekian, A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00756 · Cited by 32
Ramatillah, D. L., Gan, S. H., Pratiwy, I., Sulaiman, S. A. S., Jaber, A. A. S., Jusnita, N., Lukas, S., & Bakar, U. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262438 · Cited by 32
Xu, A., Wu, D., Zhang, R., Fan, S., Lebedev, А. T., & Zhang, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134695 · Cited by 32
Self-citationThe first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up
Muñóz, P., Galar, A., Catalán, P., Valerio, M., Aldámiz‐Echevarría, T., Cólliga, C., & Bouza, E. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/072.2020 · Cited by 31
COVID-19 and olfactory dysfunction - an ENT perspective to the current COVID-19 pandemic
Vroegop, A. V. M. T., Eeckels, A., Rompaey, V. V., Abeele, D. V., Schiappoli, M., Alobid, I., Hummel, T. R., Dorlodot, C. D., Levie, P., Huart, C., et al. (2020) · B-ENT · doi:10.5152/b-ent.2020.20127 · Cited by 31
Saavedra, D., Añé-Kourí, A. L., Sánchez, N., Filgueira, L. M., Betancourt, J. R., Herrera, C., Manso, L., Chávez, E., Caballero, A., Hidalgo, C., et al. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00207-8 · Cited by 33
Meng, J., Ma, Y., Jia, J., Wang, M., Teng, J., Shi, H., Liu, H., Su, Y., Ye, J., Sun, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603389 · Cited by 31
Self-citationShahin, K., Zhang, L., Mehraban, M. H., Collard, J., Hedayatkhah, A., Mansoorianfar, M., Soleimani-Delfan, A., & Wang, R. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105442 · Cited by 32
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Girgis, A. S., Panda, S. S., Kariuki, B. M., Bekheit, M. S., Barghash, R. F., & Aboshouk, D. R. (2023) · Molecules · doi:10.3390/molecules28186603 · Cited by 30
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes
Peng, H., Gao, P., Xu, Q., Liu, M., Peng, J. L., Wang, Y., & Xu, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104425 · Cited by 30
How do arbidol and its analogs inhibit the SARS-CoV-2?
Aktaş, A., Tüzün, B., Taskin, A. H., Sayın, K., & Ataseven, H. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_115 · Cited by 30
Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress
Hossain, M. J., & Rahman, S. M. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1864327 · Cited by 32
Chua, P. E. Y., Shah, S. U., Gui, H., Koh, J., Somani, J., & Pang, J. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-001858 · Cited by 30
Rafat, Z., Ramandi, A., Khaki, P. A., Ansari, S., Ghaderkhani, S., Haidar, H., Tajari, F., Roostaei, D., Ghazvini, R. D., Hashemi, S. J., et al. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101588 · Cited by 31
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
Sahin, G., Dağıstan, Ö. A., Culha, M., Erturk, A., Basarir, N. S., Sancar, S., & Yıldız-Peköz, A. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.06.004 · Cited by 30
Wu, A., Shi, K., Wang, J., Zhang, R., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115923 · Cited by 31
Self-citationMarkovskaya, Y., Gavioli, E. M., Cusumano, J. A., & Glatt, A. E. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.253 · Cited by 30
Stukas, S. K., Hoiland, R. L., Cooper, J. G., Thiara, S., Griesdale, D. E. G., Thomas, A. D., Orde, M. M., English, J. C., Chen, L. Y. C., Foster, D., et al. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000203 · Cited by 31
Thelen, J. M., Buenen, A. G., van Apeldoorn, M., Wertheim, H. F. L., Hermans, M. H. A., & Wever, P. C. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05902-5 · Cited by 29
Sankrityayan, H., Kale, A., Sharma, N., Anders, H., & Gaikwad, A. B. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420921720 · Cited by 29
Calvo‐Henríquez, C., Maldonado-Alvarado, B., Chiesa-Estomba, C. M., Rivero-Fernández, I., Sanz-Rodriguez, M., Villarreal, I. M., Rodriguez-Iglesias, M., Mariño‐Sánchez, F., Rivero‐de‐Aguilar, A., Lechien, J. R., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06131-3 · Cited by 28
Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
Li, L., Wang, X., Wang, R., Hu, Y., Jiang, S., & Lu, X. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s259058 · Cited by 33
Current Scenario and Future Prospect in the Management of COVID-19
Borah, P., Deb, P. K., Deka, S., Venugopala, K. N., Singh, V., Mailavaram, R. P., Kalia, K., & Tekade, R. K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908113642 · Cited by 29
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome
Azar, M. M., Shin, J. J., Kang, I., & Landry, M. L. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1830760 · Cited by 30
Dashatan, N. A., Koushki, M., Ghorbani, F., & Naderi, N. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 28
Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., Md, S., Nair, A. B., & Deb, P. K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.606393 · Cited by 28
A review on how to do hematology consults during COVID-19 pandemic
Sahu, K. K., & Černý, J. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100777 · Cited by 29
Metadata
- Authors
- Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R.
- Affiliations
- Wuhan Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Corresponding author
- Zhang, Ruiguang
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-16
- Volume
- 71
- Issue
- 15
- Pages
- 769-777
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184452
- OpenAlex
- W3012492786
- Cited by
- 1,063
- References
- 28
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 32 · 2023: 92 · 2022: 120 · 2021: 288 · 2020: 516
- FWCI
- 33.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, clinical features, mortality, oxygen saturation, comorbidities, inflammatory cytokines, interleukin-6, IL-10, C-reactive protein, lactate dehydrogenase, arbidol, antiviral therapy, hospitalized patients
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, C-Reactive Protein, China, Cough, Female, Fever, Hospitalization, Humans, Male, Middle Aged, Patient Discharge, Pneumonia, Viral, Interleukin-6, Interleukin-10, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
